title: Safety of Haemophilus influenzae conjugate vaccine in children born to HIV-1 infected mothers: Kigali (Rwanda), 1992-1994.
authors.forename: V
authors.initials: V
authors.lastname: Leroy
authors.forename: J
authors.initials: J
authors.lastname: Ladner
authors.forename: F
authors.initials: F
authors.lastname: Nsengumuremyi
authors.forename: F
authors.initials: F
authors.lastname: Dabis
authors.forename: A
authors.initials: A
authors.lastname: Simonon
authors.forename: R
authors.initials: R
authors.lastname: Salamon
mesh_terms: D002648:Child; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000276:immunology / Q000503:physiopathology*; D015497:HIV-1; D018073:Haemophilus Vaccines / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011446:Prospective Studies; D012432:Rwanda; D013745:Tetanus Toxoid / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018073:Haemophilus Vaccines; C055753:Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate; D013745:Tetanus Toxoid